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In kinetoplastid protozoa such as Leishmania myo-inositol
plays an especially important role as the precursor for various
inositol phospholipids found in the great majority of surface
molecules in these parasites. These include glycosyl-phosphatidylinositol-anchored surface proteins such as the major surface
glycoprotein, gp63 (1, 2), or abundant inositol-containing glycolipids such as lipophosphoglycan (3) and glycoinositolphos* This work was supported in part by National Institutes of Health
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pholipids (4). Several of these surface molecules are involved in
the invasion of macrophages in the mammalian host or the
attachment of the parasite to the epithelium of the insect
midgut. Strikingly, these glycosyl-phosphatidylinositol-anchored surface proteins and glycosyl-phosphatidylinositol-related glycolipids are several orders of magnitude more abundant on the surface of these parasites than in the mammalian
host (5).
In a previous study (6), we cloned a myo-inositol transporter
(MIT)1 from the parasitic protozoan Leishmania donovani, the
causative agent of fatal visceral leishmaniasis and an increasing health problem as an opportunistic infection in immunocompromised individuals (7, 8). MIT shows significant amino
acid similarity with two inositol transporters from the yeast
Saccharomyces cerevisiae, ITR1 and ITR2 (9), and is a member
of the 12-transmembrane domain sugar transporter superfamily (10, 11). Functional expression of MIT in Xenopus laevis
oocytes has revealed that it is an active myo-inositol/proton
symporter driven by a proton gradient across the cell membrane (12). Subsequently, voltage clamp recording was used to
characterize a 1:1 stoichiometry of transport with an ordered
binding of a proton followed by a molecule of myo-inositol and
subsequent transport of both molecules across the membrane
(13). Finally, immunolocalization studies revealed that this
transporter is expressed on the plasma membrane, flagellar
pocket, and flagellum of the parasite (12).
Many transport processes in these flagellates are thought to
be proton-driven, and MIT thus presents an excellent model for
the study of one such proton symporter in Leishmania. A plasma-membrane proton ATPase has been identified in L. donovani (14), which can provide the transmembrane proton gradient for active secondary transporters. Knowledge of the
function of protozoan transporters is still very limited, but from
studies in prokaryotes, proton relay across cell membranes is
thought to involve negatively charged amino acids within membrane-spanning domains (15). Two well studied examples are
the lactose/H1 symporter lac permease of Escherichia coli (16)
and bacteriorhodopsin of halobacteria (17). Extensive mutagenesis of lac permease has revealed only four amino acids
essential for transport, and all are thought to be charged transmembrane residues (18). In addition, studies with the melibiose permease from E. coli (19) have defined a role for transmembrane aspartate residues in interaction with the
counterions H1 or Na1.
We chose the Leishmania myo-inositol/proton symporter

1
The abbreviations used are: MIT, myo-inositol transporter from
Leishmania; TM, transmembrane domain; ITR, inositol transporter
from S. cerevisiae; AraE, arabinose transporter from E. coli; GalP,
galactose transporter from E. coli; XylE, xylose transporter from E. coli;
GLUT1, mammalian glucose transporter 1; FCCP, carbonylcyanide-4(trifluoromethoxy)phenylhydrazone; PBS, phosphate-buffered saline;
BSA, bovine serum albumin.
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The protozoan flagellate Leishmania donovani has an
active myo-inositol/proton symporter (MIT), which is
driven by a proton gradient across the parasite membrane. We have used site-directed mutagenesis in combination with functional expression of transporter mutants in Xenopus oocytes and overexpression in
Leishmania transfectants to investigate the significance
of acidic transmembrane residues for proton relay and
inositol transport. MIT has only three charged amino
acids within predicted transmembrane domains. Two of
these residues, Asp19 (TM1) and Glu121 (TM4), appeared
to be critical for transport function of MIT, with a reduction of inositol transport to about 2% of wild-type
activity when mutated to the uncharged amides D19N or
E121Q and 20% (D19E) or 4% (E121D) of wild-type activity for the conservative mutations that retained the
charge. Immunofluorescence microscopy of oocyte cryosections showed that MIT mutants were expressed on
the oocyte surface at a similar level as MIT wild type,
confirming that these mutations affect transport function and do not prevent trafficking of the transporter to
the plasma membrane. The proton uncouplers carbonylcyanide-4-(trifluoromethoxy)phenylhydrazone and dinitrophenol inhibited inositol transport by 50 –70% in
the wild-type as well as in E121Q, despite its reduced
transport activity. The mutant D19N, however, was
stimulated about 4-fold by either protonophore and
2-fold by cyanide or increase of pH 7.5 to 8.5 but inhibited at pH 6.5. The conservative mutant D19E, in contrast, showed an inhibition profile similar to MIT wild
type. We conclude that Asp19 and Glu121 are critical for
myo-inositol transport, while the negatively charged
carboxylate at Asp19 may be important for proton coupling of MIT.

Site-directed Mutants of Leishmania Inositol/H1 Symporter

FIG. 1. Secondary structure model of MIT. Boxed areas indicate
the 12 putative hydrophobic transmembrane domains, based on hydropathy analysis of the amino acid sequence (6, 42). Single-letter code
is used to denote the acidic amino acids altered by site-directed mutagenesis. In italics are two amino acids that are critical for transport
function of MIT as revealed from the functional expression of the
mutants in this study. Asp19 and Glu121 are located within putative
transmembrane domains (shaded boxed areas), which are potential
candidates for mapping the substrate permeation pathway of MIT.

MATERIALS AND METHODS

Parasite Culture and MIT Expression in Oocytes—Promastigotes of
the L. donovani DI-700 clone (Sudan strain 1S; Ref. 20) were cultured
at 27 °C in Dulbecco’s modified Eagle’s medium, adapted for Leishmania (DME-L medium; Ref. 21), containing 0.3% bovine serum albumin
(fraction V; Sigma) to replace fetal calf serum. Defolliculated stage
V–VI X. laevis oocytes were microinjected with 8 –10 ng (40 nl) of capped
MIT cRNA, which was transcribed in vitro from linear MIT.pL2–5
template DNA by T7 RNA polymerase (Promega) as described previously (22). Injected oocytes were incubated for 3–5 days at 16 °C and 80
rpm shaking in ND-96 buffer (22) supplemented with 2.5 mM sodium
pyruvate, 0.5 mM theophylline, and 50 mg/ml gentamycin.
Site-directed Mutagenesis—Oligonucleotide-directed, site-specific in
vitro mutagenesis (23) was a modification of the procedure of Titus (24).
Single-stranded DNA mutagenesis template was prepared from
MIT.pL2–5 plasmid as described (25). Briefly, 0.06 pmol of singlestranded DNA mutagenesis template was annealed with 1.7 pmol of
phosphorylated mutagenic oligonucleotide (Table I) for 5 min at 75 °C,
gradually cooled down to 45 °C within 30 min and to room temperature
within 10 min. Mutant strand synthesis by primer extension and ligation was carried out for 90 min at 37 °C using 8 units of T4 DNA
polymerase (Promega) and 3 units of T4 DNA ligase (Promega). Onetenth of this mutagenesis reaction (about 10 ng of template DNA) was
transformed into the E. coli ES1301 mut S strain to suppress in vivo
mismatch repair (26) and amplified in liquid culture under ampicillin
selection. Subsequently, 1 ng of mut S-derived plasmid DNA was transformed into E. coli XL-1 Blue cells and individual colonies were selected
from agar plates. Mutagenic oligonucleotides were designed to generate
the appropriate aspartate or glutamate mutation and to introduce
simultaneously a silent restriction endonuclease site alteration (Table
I). Mutant clones were identified by restriction enzyme mapping with a
yield of 20 –50% of mutants. The presence of the mutation was later
verified by DNA sequencing using the dideoxy chain termination
method (27). For the mutations affecting inositol uptake (D19N, D19E,
E121Q, E121D), the entire mutant gene was sequenced to confirm the
introduction of the desired mutation and the absence of any other
sequence alterations.
Plasmid Constructs and Transfection into Leishmania—For expression of the MIT gene in oocytes, MIT (formerly designated D1; Ref. 6)
was subcloned into the Xenopus expression vector pL2–5 (Ref. 28;
kindly provided by Dr. Susan Amara, Vollum Institute) as reported by
Drew et al. (12) to produce the MIT.pL2–5 plasmid. For overexpression
of the MIT gene in L. donovani promastigotes, the MIT HindIII-HindIII
insert of MIT.pL2–5 was subcloned into the Leishmania expression

vector pX-H, derived from vector pX (Ref. 29; kindly provided by Dr.
Stephen Beverley, Harvard Medical School) by introducing a HindIII
site into the BamHI site of pX, to produce the MIT.pX-H plasmid.
Transfection of the MIT.pX-H plasmid into L. donovani promastigotes
was performed by electroporation as described previously (30), and
transfectants were selected in liquid medium containing 200 mg/ml
neomycin analog G418 (Life Technologies, Inc.).
Transport Assays—For transport assays in Leishmania and oocytes,
myo-[2-3H]inositol (specific activity of 21 Ci/mmol; NEN Life Science
Products) was utilized. Promastigotes from middle to late log phase L.
donovani culture, transfected with MIT.pX-H, were washed twice in
phosphate-buffered saline (PBS, pH 7.4) and resuspended in PBS.
Transport was measured at 25 °C and initiated by adding 100 ml of cells
(5 3 107) to 100 ml of radiolabeled myo-inositol at 50 mM final concentration in PBS. At various time points between 10 and 120 s, transport
was stopped by spinning the cells through an oil cushion of 100 ml of
dibutyl phthalate in a microcentrifuge tube, followed by immediate
snap freezing of the tube in a dry ice/ethanol bath. The tip of the tube
with the frozen cell pellet was then clipped off into 250 ml of 1% SDS,
mixed with 2 ml of EcoLume (ICN, Costa Mesa, CA), and analyzed by
liquid scintilation counting. The initial myo-inositol uptake rate was
determined by linear regression analysis from the linear uptake range
for the various transfectants.
Transport measurements in Xenopus oocytes were performed at
room temperature and initiated by adding three or four oocytes to 300
ml of radiolabeled myo-inositol (50 mM to 3 mM final concentration) in
ND-96 buffer. After 30 min of incubation, the oocytes were washed
three times in 2 ml each of ND-96 buffer. Subsequently, each oocyte was
individually solubilized in 250 ml of 1% SDS and analyzed by liquid
scintilation counting in EcoLume as described above. Water-injected
oocytes served as control for MIT-specific inositol uptake determination. For inhibitor studies, protonophores or other potential inhibitors
(applied from an ethanol stock solution) were preincubated with the
oocytes for 10 min prior to the initiation of uptake assays, and cells
incubated with 1% ethanol served as control. Statistical analysis of the
data was performed by the paired sample t test, and all p values are
two-tailed (31). For the substrate saturation kinetics, Km and Vmax
values were determined by least squares fit of the data to the MichaelisMenten equation, employing the Levenberg-Marquardt algorithm
(KaleidaGraph program, Synergy Software) (22).
Confocal Immunofluorescence Microscopy—Antibody against the
136-amino acid hydrophilic COOH-terminal domain of MIT (MITCOOH) was produced against an MIT-COOH glutathione S-transferase
fusion protein (12). For MIT immunolocalization in oocyte cryosections,
MIT-expressing oocytes (four per wild-type or mutant) were fixed in 3%
formaldehyde/PBS for 2 h at room temperature, infiltrated with 20%
sucrose/PBS overnight at 4 °C, and embedded in Tissue-Tek O.C.T.
compound (Sakura Finetek U.S.A., Torrance, CA) for at least 5 h at
room temperature (32). Embedded samples were rapidly frozen in dry
ice, and semithin cryosections (8 –10 mm) were cut on a cryostat,
mounted on poly-L-lysine-coated slides, dried, and stored at 220 °C.
Subsequently, MIT protein was immunolocalized in oocyte sections
blocked with 5% BSA in PBS for 10 min, followed by a 1-h incubation
with MIT-COOH rabbit antiserum (diluted 1:100 in 1% BSA/PBS) and
Texas Red-conjugated secondary antibody (Molecular Probes, Eugene,
OR; diluted 1:500 in 1% BSA/PBS) for 30 min. Oocyte sections were
examined with a Leica confocal laser-scanning microscope (Leica
Lasertechnik GmbH, Heidelberg, Germany) with a Leitz 3 63 oil immersion lens as described previously (30). All oocytes in Fig. 4 came
from the same batch, and for each mutant, oocytes from the same
microinjection were tested for mutant-specific inositol uptake prior to
the embedding procedure.
RESULTS

Inositol Uptake in MIT Mutants—As shown in Fig. 2, alteration of either Asp19 (TM1) or Glu121 (TM4) from the charged
carboxylate to the uncharged amide reduced transport activity
to about 2% of wild-type activity when the mutants were expressed in Xenopus oocytes. For all measurements in oocytes,
MIT-specific inositol uptake was determined by subtracting the
values of water-injected control oocytes from the same batch for
each experiment, and the resulting D19N-specific and E121Qspecific inositol uptake, although low, was significantly different from the background level of water-injected oocytes, with
p , 0.01 and p , 0.02, respectively (paired sample t test). The
mutant D32N in extracellular loop 1 served as control and did
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MIT as a model system for active transporters in lower eukaryotes. Examination of the MIT sequence revealed that this
protein has only three charged amino acids within predicted
transmembrane domains: aspartate 19, glutamate 95, and glutamate 121 (Fig. 1). In this study, we have used site-directed
mutagenesis, in combination with functional expression of MIT
mutants in X. laevis oocytes and overexpression in L. donovani,
to investigate the significance of these acidic transmembrane
residues in MIT for inositol uptake.
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TABLE I
Mutations introduced into MIT
Italics indicate nucleotides replaced in mutants. The affected codon is underlined. Colons indicate beginning and end of the affected restriction
endonuclease recognition sequence with the cutting site marked by an asterisk. The mutagenic primer is in antisense orientation and was annealed
to single-stranded template DNA of sense orientation. Nucleotide position is numbered in sense orientation according to Langford et al. (6).
MIT

D19N
D19E
D32N
E95Q
E121Q
E121D

Mutagenic primer

59-GAT:GAC GC*C CGT GTT:ATA GCC
59-GAT:GAC GC*C CGT T TC:ATA GCC
59-GAA GCC:GAA GT*G GTTC:TT CAT
59-CAC GAG CAC CAC TT:G CAC*ATT
59-CGG CGA TGT TAC TT:G*CGC:CAG
59-TGT TAC GTC CGC CAG GTA C:AC

GAA GAG-39
GAA GAG-39
CTG GAA-39
TGG G:GC-39
GTA CAC-39
AG*G A:AT GGT GGC-39

not affect inositol uptake significantly. One of the acidic transmembrane residues, Asp95 (TM3), also showed no effect when
mutated (Fig. 2). Subsequent transfection and overexpression
of MIT in Leishmania confirmed the significance of Asp19 and
Glu121 for MIT transport function. Transport was reduced by
96 and 97%, respectively, in flagellates overexpressing the two
mutants compared with MIT wild-type overexpressors (Fig. 2).
MIT overexpressors showed 21-fold higher inositol uptake compared with endogenous MIT transport activity of Leishmania
transfected with the vector alone, and inositol transport in
D19N- and E121Q-overexpressing parasites was also significantly different from endogenous MIT transport (p , 0.01 and
p , 0.06, respectively). Finally, growth of transfected parasites
under drug selection did not affect MIT activity, with 72.4 6
13.7 pmol/min and 70.7 6 5.6 pmol/min per 108 cells in pX-Htransfected flagellates and untransfected Leishmania, respectively (Fig. 2).
As a next step, we mutated the two residues affecting inositol

Nucleotide
change

Restriction site
alteration

730
732
769
958
1036
1023, 1038

G3A
C3A
G3A
G3C
G3C
A 3 T, A 3 C

DrdI site lost
DrdI site lost
New XmnI site
BsiYI site lost
New CfoI site
BsrI site lost

uptake to the alternative carboxylate form and thus retained
the charge. These conservative mutations both showed a significant reduction on inositol uptake compared with MIT wild
type, but inositol uptake was 11-fold higher in D19E and 2-fold
higher in E121D than in the respective nonconservative mutations to the uncharged amide (Fig. 2). Thus, amino acid side
chain length appears to be more restricted for the negative
charge at position 121 than for the apparently more flexible
negative charge at position 19.
Substrate saturation kinetics revealed that the transporter’s
substrate affinity was not significantly changed in the two
mutants affecting inositol uptake, instead demonstrating a
dramatic reduction of the Vmax values by 97% (D19N) and 98%
(E121Q) compared with MIT wild-type activity (Fig. 3 and
Table II). Alternative monovalent cations such as Li1 or Rb1 at
1 mM concentration in the uptake buffer could not restore
inositol transport activity in the two mutants with reduced
inositol uptake (data not shown).
Immunolocalization of MIT Mutants on Oocyte Plasma Membrane—Immunofluorescence microscopy of oocyte cryosections
showed that MIT mutants were expressed on the oocyte surface
in similar quantity as MIT wild type (Fig. 4), confirming that
these mutations affect transport function, inhibiting inositol
uptake up to 98%, and do not prevent trafficking of the transporter to the plasma membrane. Water-injected oocytes served
as control and did not show any plasma membrane staining
(Fig. 4). MIT was expressed homogeneously over the entire
oocyte plasma membrane of both animal and vegetal pole. The
results shown in Fig. 4 were confirmed by examining four
separate oocytes expressing each MIT mutant.
Effect of Proton Gradient Uncouplers and pH on Inositol
Uptake by MIT Mutants—Subsequently, we investigated the
effect of two protonophores and uncouplers on the various
mutants. The proton gradient uncouplers FCCP and dinitrophenol inhibited inositol transport by 50 –70% in the wild-type
as well as in the control mutant D32N. The same protonophore
sensitivity was found in the MIT mutants E95Q and E121Q,
despite the reduced transport activity of the latter one (Fig. 5).
Surprisingly, one mutant, D19N, completely lost all inhibition
and instead was stimulated about 4-fold by either protonophore
(statistical significance: p , 0.002, paired sample t test). Subsequently, we further investigated the pharmacology and pH
dependence of this interesting Asp19 mutant (Table III). Phenol
did not show the stimulatory effect on D19N and served as
control for the protonophore effect of dinitrophenol, separating
from its effects as an organic solvent. Monensin had no effect on
inositol uptake in any of the Asp19 mutants or MIT wild type,
and as a Na1 ionophore it served as control for the H1 specificity of the D19N effect (Table III, top). Finally, cyanide
showed a similar effect as the protonophores and inhibited MIT
wild type and the D19E mutant 44 –50% but stimulated inositol uptake about 2-fold in the D19N mutant (p , 0.02). This
latter reagent was used to indirectly reduce the proton gradient
by affecting H1-ATPase activity, due to the inhibition of cyto-
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FIG. 2. myo-Inositol uptake in MIT mutants expressed in X.
laevis oocytes or overexpressed in Leishmania parasites. For
uptake studies in oocytes (left), in vitro transcribed cRNA was microinjected at a concentration of 8 –10 ng/oocyte. After 3 days of expression,
uptake of myo-[3H]inositol was assayed at 50 mM substrate concentration for 30 min. Values represent means 6 S.D. of four or five independent experiments (number in parenthesis) with three or four oocytes
each, after subtracting the values for water-injected oocytes as control.
Wild-type inositol uptake was 51.4 6 11.7 pmol/30 min/oocyte. For
uptake studies in L. donovani parasites (right), MIT wild type and
mutants were subcloned into the Leishmania expression vector pX-H
(containing neor) and transfected into promastigote cells. myo-[3H]
Inositol uptake is given as a percentage relative to wild-type activity
(1526.7 6 290.5 pmol/min/108 cells) after subtraction of endogenous
inositol uptake (cross-hatched area) of control cells transfected with the
vector (pX-H) alone. Solid bars in both panels indicate mutants for
which inositol transport was significantly different (p , 0.001) from
MIT wild type, analyzed by paired sample t test.

Nucleotide

Site-directed Mutants of Leishmania Inositol/H1 Symporter

FIG. 4. Confocal immunofluorescence micrographs of MIT-expressing oocytes. Oocytes were injected with cRNA or water as control and assayed for inositol uptake as described for Fig. 2. For immunolocalization, oocytes from the same batch were fixed in 3%
formaldehyde/PBS, infiltrated with 20% sucrose/PBS, and embedded in
O.C.T. compound. Samples were rapidly frozen in dry ice, and semithin
cryosections (8 –10 mm thick) were cut for subsequent immunolocalization by anti-MIT polyclonal antibody, followed by Texas Red-conjugated
secondary antibody and confocal microscopy analysis. A representative
sector of an oocyte is shown in each panel containing the plasma
membrane (immunostained against MIT proteins) and the unstained
cytoplasm beneath. WT, wild-type.

TABLE II
Kinetics of inositol uptake in MIT mutants
Substrate saturation kinetics of myo-inositol uptake were determined
in Xenopus oocytes injected with 8 –10 ng of in vitro transcribed cRNA.
A substrate concentration range of 50 mM to 3 mM myo-inositol was
used. The means 6 S.D. from three or four independent experiments
(number on the right), each performed with three or four oocytes, are
shown. Vmut/Vwt was obtained by dividing each Vmax value by the Vmax
determined for the wild-type transporter.

Wild type
D19N
D32N
E95Q
E121Q

Km

Vmax

mM

pmol/30 min/oocyte

%

465 6 152
16 6 2.5
556 6 136
556 6 166
10 6 1.0

100
3.4 6 0.5
120 6 29
120 6 36
2.2 6 0.2

640 6 144
509 6 229
554 6 147
699 6 277
437 6 121

Vmut/Vwt

n

4
4
3
3
3

chrome activity and reduction of ATP levels in the cells.
A reversal of pH dependence of inositol uptake in the D19N
mutant compared with MIT wild type and D19E (Table III,
bottom) further supported the results obtained by the proton
gradient uncouplers. Inositol uptake in the D19N mutant was
stimulated about 1.7-fold when the extracellular proton concentration was reduced from pH 7.5 to pH 8.5, whereas MIT
wild type was inhibited about 60% at pH 8.5. Conversely, an
increased extracellular proton concentration at pH 6.5 stimulated inositol uptake in MIT wild type about 3.5-fold compared
with pH 7.5, while D19N was inhibited about 10% (Table III,
bottom). The cumulative data in Table III show that the conservative mutant D19E has the same inhibition profile as MIT
wild type and, together with the other controls, suggest that
the stimulatory effect of protonophores or reduced extracellular
proton concentration upon D19N results from the removal of
the charge of the carboxylate and a reduction of the cell’s
proton gradient. These results underscore the probable importance of aspartate 19 in proton symport, although we do not

FIG. 5. Effect of protonophores on inositol uptake. Xenopus
oocytes were injected with MIT cRNA and assayed for myo-inositol
uptake in the presence of protonophore FCCP or dinitrophenol (DNP) or
1% ethanol as control. Water-injected oocytes with identical treatment
served as control to determine MIT-specific inositol uptake. Inhibition
data are expressed relative to the control for each mutant independently (mean 6 S.D.). The number of independent experiments for each
mutant, each performed with three or four oocytes, is given in
parentheses.

currently understand how this stimulation occurs. One possibility is that alteration of the transporter’s protonation may
lead to conformational changes in the D19N mutant and the
observed stimulatory effect on inositol transport.
DISCUSSION

Acidic amino acid residues have been shown to be important
in translocation of protons across membranes in bacteriorhodopsin, where Asp85 and Asp96 have been postulated to play
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FIG. 3. Concentration-dependent inositol uptake in MIT mutants. A, substrate saturation kinetics were determined in MIT-expressing oocytes for a concentration range of 50 mM to 3 mM myo-inositol
(mean 6 S.D. of three or four independent experiments). For each data
point, the average nonspecific inositol uptake by control water-injected
oocytes was subtracted as described for Fig. 2. B, enlargement for the
D19N and E121Q mutants with reduced inositol transport activity (a
representative uptake curve of four or three independent experiments,
respectively, is shown).
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TABLE III
Pharmacology and pH dependence of inositol uptake in MIT wild type and D19 mutants
Xenopus oocytes were injected with in vitro transcribed MIT cRNA and assayed for myo-inositol uptake in the presence of (top) various inhibitors
or 1% ethanol as control, or (bottom) various pH values of the uptake medium. Water-injected oocytes served as control to determine MIT-specific
inositol uptake. Data were obtained at 50 mM inositol concentration from three or six independent experiments (number in parentheses) with three
or four oocytes each (mean 6 S.D.); 100% inositol uptake equal to 51.4, 0.93, or 10.5 pmol/30 min/oocyte for MIT wild type, D19N, or D19E mutant,
respectively. Statistical significance compared with wild-type: *, p , 0.10; **, p , 0.02; ***, p , 0.002 (paired sample t test).
Inositol uptake
Wild-type

D19N

D19E

% (inhibitor/control)

Inhibitor
Control, 1% ethanol (6)
FCCP, 10 mM (6)
DNP, 1.5 mM (3)
Phenol, 1.5 mM (3)
Monensin, 2 mM (3)
NaCN, 1 mM (3)

100
45.7 6 15.6
34.3 6 15.5
104.8 6 15.6
98.7 6 6.8
50.4 6 15.3

100
391.1 6 124.9***
399.9 6 151.7*
88.2 6 3.6
100.5 6 9.2
212.2 6 34.9**

100
56.3 6 9.9
41.6 6 17.8
89.0 6 18.6
108.0 6 5.2
56.0 6 16.2

% (pH/control)

345.9 6 52.6
100
41.2 6 3.5

direct roles in transfer of protons from inside to outside of the
membrane (17). In the lac permease, Asp325 and three positively charged residues, His322, Arg302, and Lys319, have been
proposed as important residues for transport (16). Furthermore, in the E. coli melibiose permease, the acidic transmembrane residues Asp31, Asp51, Asp55, and Asp120 have been implicated in interaction with both the H1 and Na1 cosubstrates
(19). Remarkably, alteration of these residues changes the
counterion specificity of this transporter. The apparently central role of charged transmembrane residues in transporter
function encouraged us to identify and alter, by mutagenesis,
such residues in MIT. Indeed, we have found that alteration of
two of the three charged transmembrane residues almost eliminates transport activity. Although we do not know the specific
function of Asp19 or Glu121 in MIT, these amino acids are likely
candidates to be directly involved in transport mechanism.
Conversely, alteration of Glu95 to Gln does not affect transport
function, indicating that alteration of any charged transmembrane residue is not sufficient to eliminate transport function.
Subsequently, we compared the conservation of the three
acidic transmembrane residues in MIT with five inositol and
sugar/proton symporters from bacteria and yeast (Fig. 6), all
sharing an active transport mechanism. Amino acid sequence
alignment of the corresponding transmembrane domains 1, 3,
and 4 was analyzed and quantitated through the variability
profile as the number of different amino acids occurring at each
locus (33). Asp19 and Glu121 of MIT were 100% conserved in all
six proton symporters, whereas Glu95 was not conserved, with
three different amino acids found at that locus in the six transporters (Fig. 6). Conservation of amino acids is a sign of their
potential significance with regard to protein function, and
these findings match our mutagenesis studies and underscore
the importance of Asp19 and Glu121 for MIT function. While the
MIT Asp19 position is an aspartate in these six proton symporters, it is an asparagine in the homologous facilitated diffusion
transporter GLUT1. Glu121, however, remains a glutamate in
GLUT1. The possible importance of Asp19 for proton binding is
underscored by the pharmacology of MIT wild type and Asp19
mutants (Table III). Active proton-coupled inositol transport is
found for a carboxylate side chain at residue 19 (Asp19 or
Glu19), as suggested by inhibition with protonophores or cyanide. The mutant with the uncharged amide Asn19, in contrast,
is not inhibited by proton uncouplers. Currently, we cannot
fully explain the stimulatory effect of a reduced proton gradient
upon the D19N mutant, other then a possible allosteric effect
that may be caused by changes in the protonation of the trans-

89.6 6 4.3**
100
174.5 6 35.1**

122.4 6 18.1
100
74.7 6 20.8

FIG. 6. Variability profile of MIT transmembrane domains 1, 3,
and 4 aligned with five proton symporters from bacteria and
yeast. Conservation at each site of the three transmembrane segments
is quantitated through the variability profile as the number of different
amino acids occurring at the locus (33). The plot is calculated from an
amino acid sequence alignment of MIT with two inositol transporters
from S. cerevisiae, ITR1 and ITR2, and three active sugar transporters
from E. coli, AraE, GalP, and XylE (sequence alignment according to
Refs. 11 and 12). Residues 100% conserved through all six proton
symporters are enlarged in boldface type. Note a periodicity of three to
four residues for this conservation pattern, suggestive of functionally
conserved residues along one side of an a-helical structure. Underlined
are residues Asp19, Glu95, and Glu121, respectively. Filled arrows at the
right ordinate mark the mean variability number for each transmembrane segment or MIT residues Gly13–Ile23 in TM1 (open arrow).

porter mutant. Alteration of transporter ionization was also
suggested for the increased transport activity at acidic pH for a
facilitated diffusion sugar transporter from lysosomes (34).
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results presented here suggest experiments to test the possibility that Asp19 and Glu121 are on this transport pathway,
including systematic chemical modification of residues on putative transmembrane helices 1 and 4, both in the presence and
absence of myo-inositol (40, 41).
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Homans, S. W., McConville, M. J., Mehlert, A., Milne, K. G., Ralton, J. E.,
Roy, Y. A., Schneider, P., and Zitzmann, N. (1994) Parasitology 108,
S45–S54
6. Langford, C. K., Ewbank, S. A., Hanson, S. S., Ullman, B., and Landfear, S. M.
(1992) Mol. Biochem. Parasitol. 55, 51– 64
7. de Gorgolas, M., and Miles, M. A. (1994) Nature 372, 734
8. Alvar, J. (1994) Parasitol. Today 10, 160 –163
9. Nikawa, J., Tsukagoshi, Y., and Yamashita, S. (1991) J. Biol. Chem. 266,
11184 –11191
10. Henderson, P. J. F. (1991) Curr. Opin. Struct. Biol. 1, 590 – 601
11. Baldwin, S. A. (1993) Biochim. Biophys. Acta 1154, 17– 49
12. Drew, M. E., Langford, C. K., Klamo, E. M., Russell, D. G., Kavanaugh, M. P.,
and Landfear, S. M. (1995) Mol. Cell. Biol. 15, 5508 –5515
13. Klamo, E. M., Drew, M. E., Landfear, S. M., and Kavanaugh, M. P. (1996)
J. Biol. Chem. 271, 14937–14943
14. Zilberstein, D., and Dwyer, D. M. (1988) Biochem. J. 256, 13–21
15. Nagle, J. F., and Morowitz, H. J. (1978) Proc. Natl. Acad. Sci. U. S. A. 75,
298 –302
16. Kaback, R. (1992) in Molecular Biology of Receptors and Transporters: Bacterial and Glucose Transporters (Friedlander, M., and Mueckler, M., eds) pp.
97–125, Academic Press, Inc., San Diego
17. Lanyi, J. K. (1993) Biochim. Biophys. Acta 1183, 241–261
18. Wu, J., Sun, J., and Kaback, H. R. (1996) Biochemistry 35, 5213–5219
19. Zani, M.-L., Pourcher, T., and Leblanc, G. (1993) J. Biol. Chem. 268,
3216 –3221
20. Keithly, J. S. (1976) J. Protozool. 23, 244 –245
21. Iovannisci, D. M., and Ullman, B. (1983) Parasitology 69, 633– 636
22. Langford, C. K., Little, B. M., Kavanaugh, M. P., and Landfear, S. M. (1994)
J. Biol. Chem. 269, 17939 –17943
23. Hutchison, C. A., III, Swanstrom, R., Loeb, D. D. (1991) Methods Enzymol.
202, 356 –390
24. Titus, D. E. (1991) Promega Protocols and Application Guide, pp. 98 –105,
Promega Corp., Madison, WI
25. Viera, J., and Messing, J. (1987) Methods Enzymol. 153, 3–11
26. Zell, R., and Fritz, H. J. (1987) EMBO J. 6, 1809 –1815
27. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A.
74, 5463–5467
28. Arriza, J. L., Kavanaugh, M. P., Fairman, W. A., Wu, Y.-N., Murdoch, G. H.,
North, R. A., and Amara, S. G. (1993) J. Biol. Chem. 268, 15329 –15332
29. LeBowitz, J. H., Coburn, C. M., McMahon-Pratt, and Beverley, S. M. (1990)
Proc. Natl. Acad. Sci. U. S. A. 87, 9736 –9740
30. Piper, R. C., Xu, X., Russell, D. G., Little, B. M., and Landfear, S. M. (1995) J.
Cell Biol. 128, 499 –508
31. Zar, J. H. (1984) Biostatistical Analysis, pp. 150 –153, Prentice-Hall, Englewood Cliffs, NJ
32. Lostao, M. P., Hirayama, B. A., Panayotova-Heiermann, M., Sampogna, S. L.,
Bok, D., and Wright, E. M. (1995) FEBS Lett. 377, 181–184
33. Ballesteros, J. A., and Weinstein, H. (1995) Methods Neurosci. 25, 366 – 428
34. Mancini, G. M. S., Beerens, C. E. M. T., and Verheijen, F. W. (1990) J. Biol.
Chem. 265, 12380 –12387
35. Maiden, M. C. J., Davis, E. O., Baldwin, S. A., Moore, D. C. M., and Henderson,
P. J. F. (1987) Nature 325, 641– 643
36. Pourcher, T., Zani, M.-L., and Leblanc, G. (1993) J. Biol. Chem. 268,
3209 –3215
37. Mueckler, M., Weng, W., and Kruse, M. (1994) J. Biol. Chem. 269,
20533–20538
38. Gould, G. W., and Holman, G. D. (1993) Biochem. J. 295, 329 –341
39. Lachaal, M., Rampal, A. L., Lee, W., Shi, Y., Jung, C. Y. (1996) J. Biol. Chem.
271, 5225–5230
40. Akabas, M. H., Stauffer, D. A., Xu, M., and Karlin, A. (1992) Science 258,
307–310
41. Javitch, J. A., Fu, D., Chen, J., and Karlin, A. (1995) Neuron 14, 825– 831
42. Eisenberg, D., Schwarz, E., Komaromy, M., and Wall, R. (1984) J. Mol. Biol.
179, 125–142

Downloaded from http://www.jbc.org/ at UNIV OF MONTANA on October 10, 2019

Comparison of the three transmembrane domains 1, 3, and 4
in MIT, ITR1, ITR2, AraE, GalP, and XylE (Fig. 6) revealed a
significantly higher degree of conservation in helices 1 and 4
with 66.2 and 62.0% amino acid identity, respectively, compared with helix 3 with 44.9% identity. In helix 1, identity
among the six proton symporters increases to 84.9% for the
carboxyl-terminal half of the transmembrane domain (MIT
G13-I23), which contains residue Asp19. Remarkable is a periodicity of three to four residues for the conservation pattern in
helix 1 (Ala9–Gly13–Phe16–Asp19–Ile23) and helix 4 (Gly105–
Gly109–Ser112–Pro116), suggestive of a-helical character and
orientation along a conserved and functionally important
stretch of the transmembrane segment, potentially part of the
substrate permeation pathway.
The Leishmania MIT is a member of the large sugar transporter superfamily, ranging from bacteria to plants and mammals, and this protozoan transporter serves as a model for
active transporters in early eukaryotes. The bacterial disaccharide/cation symporters, lactose permease and melibiose permease, are usually grouped in a separate family, based on
structural and functional data (35, 10, 11). For lac permease it
was demonstrated that transmembrane domains 6 –12 (designated C6) are sufficient to catalyze facilitative transport (18),
and four charged transmembrane residues essential for transport function are located in C6. This is distinct from MIT, where
charged residues important for function are in the NH2-terminal half of the carrier. However, four aspartate residues in the
NH2-terminal half of the melibiose transporter are thought to
be important for counterion binding (36), similar to the results
obtained with MIT.
Site-directed mutagenesis in the small number of transporters extensively studied has revealed that residues critical for
transport activity are rather rare, and in the mammalian glucose transporter GLUT1 only two residues (Gln161 and Trp412)
were found to greatly influence transport activity (37). These
residues lie within transmembrane domains 5 and 11, respectively, and support the idea based on ligand binding and labeling studies that the C-terminal part of GLUT1 may form the
aqueous pore for the substrate permeation pathway (11, 38). In
MIT, however, transmembrane domains 1 and 4 appear to be
important for substrate transport. The observation that either
NH2-terminal or C-terminal half of the various transporters
are implicated to align the substrate translocation pathway
may be explained by the symmetrical arrangement of two sixhelix bundles, derived from an internal gene duplication event
in an ancestral six-transmembrane domain transporter (35,
11), where one of the two six-helix bundles retains the substrate translocation pathway in the modern 12-helix transporter. However, this hypothesis has been challenged recently
by a photoaffinity labeling study of GLUT1 (39) showing evidence that not only the carboxyl-terminal half but also the
amino-terminal half of GLUT1 helices participates in the putative substrate channel formation.
In this study, we have shown the importance of two transmembrane carboxylate residues for transport function in a
protozoan proton symporter, similar to results observed with
active transporters from bacteria. These residues may play a
direct role in the transport of protons, although this conjecture
remains to be proven. For most transporters, the location of the
“permeation pathway” is still largely unknown. It is likely that
Asp19 and Glu121 are on this permeation pathway in MIT. The
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